Swedish biopharmaceutical company Sobi announced this week that beginning July 1 it will implement 340B contract pharmacy restrictions, making the [...] …
Category: Pharma Industry
340B hospitals need new transparency requirements and program eligibility rules to ensure the sustainability of the program, Republican lawmakers said [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Vertex Pharmaceuticals has become the 33rd drugmaker to place 340B contract pharmacy restrictions, but the new policy exempts all six [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker UCB recently told 340B providers in Arkansas that it will exempt them from its contract pharmacy restrictions. In a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Generic and biosimilar drugmaker Sandoz recently added a drug used in conjunction with cancer treatments to its list of drugs [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Bayer recently announced it will add a previously excluded drug to its list of products that face contract pharmacy restrictions. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal auditors recently reported no adverse findings in their first fiscal year 2024 340B audit of a pharmaceutical manufacturer. On [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal appeals court’s decision this week to uphold two drugmakers’ 340B contract pharmacy restrictions left unanswered questions about the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Teva Pharmaceuticals recently added the 40th drug to the list of medications included in its contract pharmacy policy restrictions for [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal appeals court today decided that the 340B statute does not prohibit drugmakers from placing conditions on the distribution [...] …
